Varenicline Tartrate Kit
Product Images NDC 43598-023

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Varenicline Tartrate (NDC 43598-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Label for Varenicline Tablets 1 mg by Dr. Reddys Laboratories Inc., an oral kit containing 56 tablets. The label includes dosage strength, storage instructions, pharmacist dispensing note, barcodes, and regulatory information. The product is made in India.*

FDA Label Image

Principal Display Panel (0.5 mg Tablet Bottle Label)

Label for Varenicline Tablets 0.5 mg by Dr. Reddys Laboratories Inc., a human prescription drug kit for oral use. The label indicates it contains 56 tablets and includes instructions for the pharmacist to dispense the Medication Guide separately. It also provides storage conditions, dosage information, NDC 43598-907-56, and barcode details.*

FDA Label Image

Principal Display Panel (1 mg Tablets Continuing Carton Pack)

Packaging label for Varenicline Tablets 1 mg continuing month box by Dr. Reddy's Laboratories Inc. The kit contains 4 continuing weeks supply (1 mg tablets, 56 count total). Label includes instructions for pharmacists to dispense the Medication Guide separately and storage information. Distributed from Princeton, NJ, and made in India.*

FDA Label Image

Principal Display Panel (1 mg Tablets Continuing Wallet Pack)

Packaging label for varenicline tablets continuing pack, containing 4 continuing weeks (1 mg x 56 tablets). It features a white and pink color scheme with dosage instructions divided into weekly segments. The label displays the NDC 43598-022-56, Rx only status, and is labeled by Dr. Reddys Laboratories Inc. Instructions for removal of tablets from the blister pack are provided, along with storage information and a Medication Guide advisory for pharmacists.*

FDA Label Image

Figure 1 (Figure1)

A bar chart comparing the effects of Varenicline Tablets 0.5 mg and 1 mg with Bupropion SR 150 mg BID and placebo across five different studies. The chart shows percentage values on the vertical axis, with each study group represented by distinct bars indicating varying response levels and error bars for variability.*

FDA Label Image

Figure 2 (Figure2)

A bar chart comparing percentages related to Varenicline Tablets 0.5 mg and 1 mg versus placebo and Bupropion SR 150 mg in multiple studies labeled STUDY 2 through STUDY 5. The chart shows different percentages on the y-axis from 0% to 35%, with error bars indicating variability for each treatment group in the various studies.*

FDA Label Image

Figure 3 (Figure3)

A line graph depicting the percentage of continuous abstinent individuals over time in weeks. Two groups are compared: varenicline 1 mg BID and placebo, with varenicline showing higher abstinence rates throughout the follow-up period.*

FDA Label Image

Logo (Logo)

FDA Label Image

Principal Display Panel (0.5 / 1 mg Tablet Starting Wallet Pack Back)

Varenicline Tablets Starter Pack kit label from Dr. Reddys Laboratories Inc. The label shows an oral tablet blister pack with a starting week blister (0.5 mg strength, 7 evening doses) in orange, and three continuing week blisters (1 mg strength, 14 doses per week) in pink. The packaging includes directions for use, the NDC 43598-023-53, and instructions for pharmacists to dispense the medication guide separately.*

FDA Label Image

Principal Display Panel (0.5 / 1 mg Tablet Starting Pack Carton)

Label for Varenicline Tablets Starting Month Box by Dr. Reddy's Laboratories Inc., an oral prescription drug kit containing varenicline tartrate. The kit includes 1 Starting Week supply (0.5 mg x 11 tablets) and 3 Continuing Weeks supplies (1 mg x 42 tablets). The label details dosage instructions, storage conditions, and distributor information, with UPC and NDC 43598-023-53 codes visible.*

FDA Label Image

Principal Display Panel (0.5 / 1 mg Tablet Starting Wallet Pack Front)

Varenicline tartrate tablets kit label with blister packaging layout showing multiple doses. The kit includes tablets of 0.5 mg and 1 mg strengths for oral use. Labeler is Dr. Reddys Laboratories Inc. The label includes instructions on dosage and use, along with guidance on how to take varenicline tablets. The packaging is designed for patient use with clear dosage increments in blister packs.*

FDA Label Image

Structure (Structure)

Chemical structure diagram showing molecular components with carboxyl, hydroxyl, and nitrogen-containing bicyclic structures. This is the chemical structure representation of varenicline tartrate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.